Company: AEMD
Filing Date: 2025-11-12
Form Type: 8-K
Source: 0001683168-25-008257
Chunk: 1

Company: AETHLON MEDICAL INC
Filing Date: 2025-11-12
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item
7.01 Regulation FD Disclosure.

On November 12, 2025,
Aethlon Medical, Inc. (the “ Company”) issued a press release regarding its financial results for the quarter ended September
30, 2025. A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.

The information set forth
under Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to
the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference
language in any such filing, except as expressly set forth by specific reference in such a filing. This Current Report will not be deemed
an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.

Item 9.01 Financial Statements
and Exhibits.

  (d)      Exhibits.  

  Exhibit      Description                                                                  
      No.                                                                                   
     99.1      Press Release, dated November 12, 2025                                       
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

   2  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: November 12, 2025      Aethlon Medical, Inc.                                                           
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────
                               By:                        /s/ James B. Frakes                                  
                               Name:                      James B. Frakes                                      

   3